Summary of Purpose
The aim of this study is to find out if DS-1040b is safe and tolerable in acute ischemic stroke patients with thrombectomy. Four groups will receive different doses of DS-1040b by intravenous infusion for 6 hours. Groups with the lowest dose will start. When it is determined that each dose is safe and tolerable, the next higher dose will be given to the next group.Read More →
The following dates are available for this trial. Trial information last updated on 20 April 2018.
|30 Jul 2017||19 Jun 2017||1 Mar 2019||1 Jun 2019||1 Apr 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Daiichi Sankyo Contact for Clinical Trial Information
firstname.lastname@example.org +81-3-6225-1111(M-F 9-5 JST)